CompuGroup Accounts Payable vs Current Deferred Revenue Analysis

0MSD Stock   15.95  0.28  1.79%   
CompuGroup Medical financial indicator trend analysis is way more than just evaluating CompuGroup Medical prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether CompuGroup Medical is a good investment. Please check the relationship between CompuGroup Medical Accounts Payable and its Current Deferred Revenue accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CompuGroup Medical AG. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Accounts Payable vs Current Deferred Revenue

Accounts Payable vs Current Deferred Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of CompuGroup Medical Accounts Payable account and Current Deferred Revenue. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between CompuGroup Medical's Accounts Payable and Current Deferred Revenue is 0.5. Overlapping area represents the amount of variation of Accounts Payable that can explain the historical movement of Current Deferred Revenue in the same time period over historical financial statements of CompuGroup Medical AG, assuming nothing else is changed. The correlation between historical values of CompuGroup Medical's Accounts Payable and Current Deferred Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Accounts Payable of CompuGroup Medical AG are associated (or correlated) with its Current Deferred Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Current Deferred Revenue has no effect on the direction of Accounts Payable i.e., CompuGroup Medical's Accounts Payable and Current Deferred Revenue go up and down completely randomly.

Correlation Coefficient

0.5
Relationship DirectionPositive 
Relationship StrengthWeak

Accounts Payable

An accounting item on the balance sheet that represents CompuGroup Medical obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of CompuGroup Medical are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Current Deferred Revenue

Revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends.
Most indicators from CompuGroup Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into CompuGroup Medical current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CompuGroup Medical AG. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Selling General Administrative is likely to gain to about 47.5 M in 2024, whereas Tax Provision is likely to drop slightly above 39.6 M in 2024.
 2021 2022 2023 2024 (projected)
Interest Expense5.4M9.1M24.3M25.5M
Depreciation And Amortization110.7M112.3M115.8M121.6M

CompuGroup Medical fundamental ratios Correlations

0.590.970.880.970.960.860.931.00.740.930.660.720.790.510.070.990.990.60.970.350.570.980.62-0.240.98
0.590.60.790.570.610.850.430.60.440.430.50.830.370.18-0.160.590.550.930.510.350.220.610.84-0.260.65
0.970.60.850.960.970.850.930.970.650.930.690.760.760.420.010.980.960.620.940.440.710.970.64-0.170.97
0.880.790.850.830.80.990.850.880.660.840.490.90.660.520.120.850.870.670.850.220.50.860.77-0.330.85
0.970.570.960.830.960.830.890.970.670.890.660.680.870.480.050.970.970.610.940.390.590.970.62-0.210.97
0.960.610.970.80.960.80.860.960.650.860.760.690.780.39-0.060.980.960.680.920.450.570.980.62-0.170.99
0.860.850.850.990.830.80.810.870.620.810.490.930.640.470.080.840.840.740.810.290.510.850.83-0.30.85
0.930.430.930.850.890.860.810.930.671.00.540.680.730.50.090.920.930.380.940.30.750.920.56-0.250.89
1.00.60.970.880.970.960.870.930.740.930.650.720.770.510.080.990.990.610.960.350.560.980.63-0.230.98
0.740.440.650.660.670.650.620.670.740.670.580.360.620.24-0.090.720.730.340.760.280.190.720.25-0.110.71
0.930.430.930.840.890.860.811.00.930.670.530.680.730.490.10.920.930.380.930.310.750.920.56-0.220.89
0.660.50.690.490.660.760.490.540.650.580.530.340.59-0.11-0.630.730.70.540.720.570.320.740.34-0.320.74
0.720.830.760.90.680.690.930.680.720.360.680.340.470.440.160.690.690.750.650.250.540.690.81-0.170.72
0.790.370.760.660.870.780.640.730.770.620.730.590.470.32-0.040.810.840.340.840.410.420.80.34-0.290.8
0.510.180.420.520.480.390.470.50.510.240.49-0.110.440.320.670.440.490.160.43-0.410.280.430.35-0.130.43
0.07-0.160.010.120.05-0.060.080.090.08-0.090.1-0.630.16-0.040.67-0.020.03-0.14-0.04-0.490.04-0.060.070.36-0.04
0.990.590.980.850.970.980.840.920.990.720.920.730.690.810.44-0.020.990.620.960.420.591.00.61-0.230.99
0.990.550.960.870.970.960.840.930.990.730.930.70.690.840.490.030.990.560.980.340.560.980.57-0.280.98
0.60.930.620.670.610.680.740.380.610.340.380.540.750.340.16-0.140.620.560.470.380.20.620.8-0.130.67
0.970.510.940.850.940.920.810.940.960.760.930.720.650.840.43-0.040.960.980.470.320.570.960.5-0.330.95
0.350.350.440.220.390.450.290.30.350.280.310.570.250.41-0.41-0.490.420.340.380.320.30.410.240.10.42
0.570.220.710.50.590.570.510.750.560.190.750.320.540.420.280.040.590.560.20.570.30.590.51-0.010.55
0.980.610.970.860.970.980.850.920.980.720.920.740.690.80.43-0.061.00.980.620.960.410.590.64-0.250.99
0.620.840.640.770.620.620.830.560.630.250.560.340.810.340.350.070.610.570.80.50.240.510.64-0.20.64
-0.24-0.26-0.17-0.33-0.21-0.17-0.3-0.25-0.23-0.11-0.22-0.32-0.17-0.29-0.130.36-0.23-0.28-0.13-0.330.1-0.01-0.25-0.2-0.23
0.980.650.970.850.970.990.850.890.980.710.890.740.720.80.43-0.040.990.980.670.950.420.550.990.64-0.23
Click cells to compare fundamentals

CompuGroup Medical Account Relationship Matchups

CompuGroup Medical fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets1.1B1.6B1.8B1.9B1.9B988.6M
Other Current Liab61.2M71.5M73.5M89.6M169.4M177.9M
Total Current Liabilities236.3M290.5M398.3M375.5M346.8M220.4M
Total Stockholder Equity259.1M638.7M612.1M672.4M667.7M701.1M
Property Plant And Equipment Net131.3M136.3M158M160.9M165.7M86.1M
Net Debt467.0M479.9M634.0M696.0M702.5M355.9M
Retained Earnings221.5M273.1M310.7M611.3M702.9M738.1M
Cash43.8M74.6M107.3M90.5M64.5M42.4M
Non Current Assets Total832.9M1.3B1.4B1.5B1.5B787.0M
Non Currrent Assets Other24.5M25.3M27.4M56.3M44.2M22.7M
Cash And Short Term Investments44.7M75.6M107.6M91.0M64.5M43.1M
Net Receivables119.9M(1K)182.6M221.9M211.1M107.0M
Common Stock Shares Outstanding49.4M53.7M53.0M52.3M52.5M55.5M
Liabilities And Stockholders Equity1.1B1.6B1.8B1.9B1.9B988.6M
Inventory27.5M18.2M20.6M29.4M18.9M11.5M
Other Current Assets39.1M214.3M60.0M78.9M75.3M46.9M
Other Stockholder Equity(86.3M)531.2M(98.8M)(105.2M)(94.7M)(90.0M)
Total Liab805.9M926.8M1.2B1.3B1.2B665.6M
Total Current Assets232.9M308.1M370.8M420.8M369.8M201.6M
Accounts Payable47.1M64.5M93.2M110.6M82.3M44.0M
Short Term Debt57.9M56.3M115.7M53.3M25.9M49.4M
Short Long Term Debt Total510.8M554.5M741.3M786.5M766.9M448.1M
Current Deferred Revenue118.0M154.1M177.6M69.0M220.1M231.1M
Short Term Investments944K1.0M340K551K82K77.9K
Non Current Liabilities Total569.6M636.3M780.2M895.1M883.8M498.0M
Intangible Assets337.4M545.7M625.9M654.7M625.8M419.2M
Accumulated Other Comprehensive Income(33.1M)53.7M(45.1M)(51.5M)719.1M755.1M
Good Will330.9M542.4M588.4M639.2M684.1M414.6M
Long Term Debt318.1M302.6M424.5M470.2M540.7M402.9M
Property Plant Equipment131.3M136.3M158M160.9M185.0M129.9M
Other Liab116.7M138.1M154.6M162.0M186.3M134.3M
Net Tangible Assets(407.9M)(447.1M)(599.3M)(618.4M)(556.6M)(584.4M)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for CompuGroup Stock Analysis

When running CompuGroup Medical's price analysis, check to measure CompuGroup Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CompuGroup Medical is operating at the current time. Most of CompuGroup Medical's value examination focuses on studying past and present price action to predict the probability of CompuGroup Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CompuGroup Medical's price. Additionally, you may evaluate how the addition of CompuGroup Medical to your portfolios can decrease your overall portfolio volatility.